• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Brand Quest
• The New Manager
• Smartbuy

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth
• Events 2007

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Hyderabad, June 7

Transgene Biotek Ltd entered into a definitive agreement with Australia-based Mentor Pharmaceuticals Consulting Pty Ltd for research, development, manufacturing and marketing of several products. The products would be developed through novel delivery technologies that may include methods such as oral, transdermal or other novel delivery systems. The products to be developed include human insulin, erythropoietin, other protein, polysaccharide-based vaccines, the Hyderabad-based company said in a release. The agreement would also help accelerating Transgene's ongoing project to develop and commercialise oral delivery of human insulin, it added. - Our Bureau

More Stories on : Alliances & Joint Ventures | Bio-tech & Genetics

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Divi’s Labs annual net surges 87% on higher sales

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line